Notwithstanding these limitations, it bears repeating that a fairly rudimentary immune microenvironment parameter—namely the intra-tumoral CD8+:CD3+ lymphocyte ratio—was prognostically independent of histologic grade and tumor volume (PCI), which are two of the most consistently identified variables driving the prognosis of AC across decades of clinical research. This evidence concerns the gene CD8A and neoplasm.